InvestorsHub Logo
Followers 18
Posts 255
Boards Moderated 0
Alias Born 11/30/2020

Re: None

Saturday, 02/06/2021 3:05:45 PM

Saturday, February 06, 2021 3:05:45 PM

Post# of 197993
Just a recap for all on what we are still waiting on. Fyi I may miss a few there is a lot.

1) toxicity study update which could answer questions on next steps for FDA approval. Speculation wise we should fall under the FDA EU agreement but let's wait and see. This is for ITV-1.

2) previous 2 year audit. All the financial statements are in and have had corrections. The audit company had been selected and began in January. Hoping to get news that the 2 year audit is complete. Speculation wise that could mean an uplist. Even to the otcqb would be a step up but would love to see higher in the future.

3) Any funding updates in regards to warp speed and the NIH.

4) Updates regarding Covid and whether CLONE3 is being used in a theraputics capacity in regards to treating covid. Speculation wise we could see a partnership with other major companies working on theraputics. Recently on linked in we did hash tag elylilly. Fingers crossed.

5) updates on any other patents. We saw that we are now working on MS and that patent was filled. That's delving into waters we didn't know about 3 months ago. Speculation wise this could mean more diseases being able to be eradicated or treated my ENZC.

6) any update out of TAMU. We saw the last PR stating that we have used AI and had success. Give the company a few more months and who knows what they can do.

7) GENSCRIPT labs update. They are in the process of manufacturing. I would love to see a PR about distribution.

I know I missed some major ones but I believe these will be the most imminent items. The website being released in the coming days (also from PR) might answer some of these thoughts.

To me this has been a solid investment. Yes it is a penny stock and still high risk but this company has done everything it said it would since I have been following from September plus some. They care about their image and realize they need to work with shareholders to get this to the finish line. If you can't name one company that has done half of what they have in the last five months then you should realize why they are so unique and not staying down here for long. The history before October is irrelevant because it's all new management and a while new company with ground breaking science to better the world and may just change how other pharmas operate.

I won't speculate on price because I don't believe any of us have seen a stock like this and fully know what it will become. But I'm holding long and highly encourage our educated group of outstanding longs on here to share as much about the company as frequent as possible and how they believe as well. The stock will only move if people are educated. Most don't know how to navigate the otc pennies but if we help them we all benefit.

Good luck to all this week. And for years to come.